Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Seman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 1, 1986
Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)L J Seman, W C Breckenridge
Current Opinion in Cardiology|April 7, 1999
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factorsL J Seman, J R McNamara, E J Schaefer
MLO: Medical Laboratory Observer|February 24, 2001
The laboratory's role in identifying lipid and lipoprotein risk factors for CHDJ R McNamara, L J Seman, E J Schaefer
Methods in Molecular Biology (Clifton, N.J.)|January 26, 1999
Isolation and purification of serum lipoprotein (a) using lectin affinityL J Seman, C de Luca, J L Jenner
Atherosclerosis|August 5, 2000
Ascorbic acid supplementation does not lower plasma lipoprotein(a) concentrationsJ L Jenner, P F Jacques, L J Seman, et al.
Clinical Chemistry|March 1, 1994
Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fractionL J Seman, J L Jenner, J R McNamara, et al.
Diabetes, Obesity & Metabolism|August 3, 2013
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemiaJ Rosenstock, L J Seman, A Jelaska, et al.
Biochemistry|November 1, 1988
The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein BZ Zawadzki, F Tercé, L J Seman, et al.
Chemistry and Physics of Lipids|January 1, 1994
Lipoprotein(a) and coronary heart diseaseC R Rodriguez, L J Seman, J M Ordovas, et al.
The American Journal of Cardiology|April 18, 2001
Lipid lowering and weight reduction by home-delivered dietary modification in coronary heart disease patients taking statinsE J Schaefer, J L Augustin, J R McNamara, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|October 1, 1986
Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)L J Seman, W C Breckenridge
Current Opinion in Cardiology|April 7, 1999
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factorsL J Seman, J R McNamara, E J Schaefer
MLO: Medical Laboratory Observer|February 24, 2001
The laboratory's role in identifying lipid and lipoprotein risk factors for CHDJ R McNamara, L J Seman, E J Schaefer
Methods in Molecular Biology (Clifton, N.J.)|January 26, 1999
Isolation and purification of serum lipoprotein (a) using lectin affinityL J Seman, C de Luca, J L Jenner
Atherosclerosis|August 5, 2000
Ascorbic acid supplementation does not lower plasma lipoprotein(a) concentrationsJ L Jenner, P F Jacques, L J Seman, et al.
Clinical Chemistry|March 1, 1994
Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fractionL J Seman, J L Jenner, J R McNamara, et al.
Diabetes, Obesity & Metabolism|August 3, 2013
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemiaJ Rosenstock, L J Seman, A Jelaska, et al.
Biochemistry|November 1, 1988
The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein BZ Zawadzki, F Tercé, L J Seman, et al.
Chemistry and Physics of Lipids|January 1, 1994
Lipoprotein(a) and coronary heart diseaseC R Rodriguez, L J Seman, J M Ordovas, et al.
The American Journal of Cardiology|April 18, 2001
Lipid lowering and weight reduction by home-delivered dietary modification in coronary heart disease patients taking statinsE J Schaefer, J L Augustin, J R McNamara, et al.
Pageof 2